While matrix metalloproteinase-10 (MMP-10) was associated with MACE in diabetic individuals, matrix metalloproteinase-7 (MMP-7) was independently associated with 2-year MACE prognosis in PAD patients. Here, MMP7 is linked to peripheral arterial disease.